Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 12, Number 12—December 2006

Research

Evaluating Detection of an Inhalational Anthrax Outbreak

David L. Buckeridge*Comments to Author , Douglas K. Owens†‡, Paul Switzer‡, John Frank§, and Mark A. Musen‡
Author affiliations: *McGill University, Montreal, Quebec, Canada; †Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA; ‡Stanford University, Stanford, California, USA; §University of Toronto, Toronto, Ontario, Canada

Main Article

Figure 2

Proportion of inhalational anthrax outbreaks detected by syndromic surveillance before clinical case finding (A) and mean detection benefit of syndromic surveillance compared with clinical case finding as a function of specificity (and false-alarm rate) (B) for 3 release scenarios. CI, confidence interval.

Figure 2. Proportion of inhalational anthrax outbreaks detected by syndromic surveillance before clinical case finding (A) and mean detection benefit of syndromic surveillance compared with clinical case finding as a function of specificity (and false-alarm rate) (B) for 3 release scenarios. CI, confidence interval.

Main Article

TOP